Dent Disease
10
5
5
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Ultrasound for Socket Healing Evaluation
Prospective Research Rare Kidney Stones (ProRKS)
Rare Kidney Stone Consortium Biobank
Rare Kidney Stone Consortium Patient Registry
Evaluation of the Release of Monomers From Composite Bonding Resins in Orthodontics
National Registry of Rare Kidney Diseases
Health-related Quality of Life in Rare Kidney Stone
Dent Disease Mutation Genotyping
Role Of Phosphorus And FGF 23 In Patients With Dent Disease
Review of Kidney Biopsies of Dent Disease Patients